Skip to main content
. 2010 Oct 15;15(4):328–336. doi: 10.1111/j.1542-474X.2010.00388.x

Table 1.

Clinical and TWA Parameters (mean ± SD) for the 142 Control Healthy Subjects (77 Males and 65 Females)

Control Population (142) Control Males (77) Control Females (65) P‐Value
SAP (mmHg) 108 ± 35  112 ± 32  104 ± 40  NS
DAP (mmHg) 68 ± 23 72 ± 20 66 ± 25 NS
BMI (kg/m2) 24 ± 5  25 ± 3  24 ± 7  NS
Age (year) 39 ± 15 37 ± 13 40 ± 17 NS
MNN (ms) 886 ± 139 927 ± 144 837 ± 116 <10−4
SDNN (ms) 24 ± 17 27 ± 19 22 ± 15 NS
Mean TWA duration (beat) 58 ± 15 52 ± 14 65 ± 13 <10−6
Mean TWA amplitude (μV) 35 ± 12 35 ± 12 34 ± 11 NS
Mean TWA product (beat·μV) 2085 ± 899  1913 ± 772  2290 ± 998  NS
TWA duration SD (beat) 9 ± 3 10 ± 4  9 ± 2 NS
TWA amplitude SD (μV) 6 ± 4 7 ± 4 5±3 NS
TWA product SD (beat·μV) 523 ± 289 539 ± 327 505 ± 238 NS

P‐value refers to statistical comparison between control‐male and control‐female groups. P < 10−4 and P < 10−6, statistical significance (unpaired Student's t‐test with Bonferroni's method).

NS: no significant difference (P ≥ 0.006).